florbetaben   Click here for help

GtoPdb Ligand ID: 7769

Synonyms: [18F]BAY 94-9172 [1] | AV-1 [2] | BAY 94-9172 [2] | Neuraceq®
Approved drug  Ligand is labelled  Ligand is radioactive
florbetaben is an approved drug (EMA & FDA (2014))
Compound class: Synthetic organic
Comment: Florbetaben F18 is the third PET (positron-emission tomography) reagent approved to identify amyloid-β (Aβ) as a diagnostic biomarker in the brains of patients with Alzheimer's disease (AD) [1]. Flutemetamol and florbetapir are the two other PET reagents approved for Aβ detection. These diagnostic tools allow direct and non-invasive in vivo visualisation and quantification of Aβ.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 12
Topological polar surface area 39.72
Molecular weight 359.19
XLogP 4.46
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FCCOCCOCCOc1ccc(cc1)C=Cc1ccc(cc1)NC
Isomeric SMILES [18F]CCOCCOCCOc1ccc(cc1)/C=C/c1ccc(cc1)NC
InChI InChI=1S/C21H26FNO3/c1-23-20-8-4-18(5-9-20)2-3-19-6-10-21(11-7-19)26-17-16-25-15-14-24-13-12-22/h2-11,23H,12-17H2,1H3/b3-2+/i22-1
InChI Key NCWZOASIUQVOFA-FWZJPQCDSA-N
No information available.
Summary of Clinical Use Click here for help
Florbetaben is approved as a tool to help identify the presence of amyloid-β (Aβ) as a diagnostic biomarker in the brains of patients with Alzheimer's disease (AD) [1].
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Intravenously administered florbetaben crosses the blood-brain-barrier where it selectively binds to the Aβ contained in the plaques that are hypothesised to be mechanistically involved in the development of Alzheimer's disease. The 18F radioactive tracer can then be detected by PET scanning and its accumulation and distribution computationally analysed.
External links Click here for help